MA42055A - Composés antimicrobiens et procédés de fabrication et d'utilisation de ceux-ci - Google Patents
Composés antimicrobiens et procédés de fabrication et d'utilisation de ceux-ciInfo
- Publication number
- MA42055A MA42055A MA042055A MA42055A MA42055A MA 42055 A MA42055 A MA 42055A MA 042055 A MA042055 A MA 042055A MA 42055 A MA42055 A MA 42055A MA 42055 A MA42055 A MA 42055A
- Authority
- MA
- Morocco
- Prior art keywords
- processes
- manufacturing
- same
- antimicrobial compounds
- antimicrobial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562131751P | 2015-03-11 | 2015-03-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA42055A true MA42055A (fr) | 2018-03-14 |
Family
ID=56879869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA042055A MA42055A (fr) | 2015-03-11 | 2016-03-11 | Composés antimicrobiens et procédés de fabrication et d'utilisation de ceux-ci |
Country Status (16)
Country | Link |
---|---|
US (1) | US10947237B2 (fr) |
EP (1) | EP3268370A4 (fr) |
JP (1) | JP2018507881A (fr) |
KR (1) | KR20180015114A (fr) |
CN (1) | CN107922418A (fr) |
AU (1) | AU2016228584A1 (fr) |
BR (1) | BR112017019349A2 (fr) |
CA (1) | CA2979342A1 (fr) |
EA (1) | EA201792006A1 (fr) |
HK (1) | HK1249758A1 (fr) |
IL (1) | IL254398A0 (fr) |
MA (1) | MA42055A (fr) |
MX (1) | MX2017011616A (fr) |
PH (1) | PH12017501646A1 (fr) |
SG (1) | SG11201707346RA (fr) |
WO (1) | WO2016145417A1 (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2488532T3 (en) | 2009-10-16 | 2018-08-13 | Melinta Therapeutics Inc | ANTIMICROBIAL COMPOUNDS AND PROCEDURES FOR PREPARING AND USING THE SAME |
SG11201601654TA (en) | 2013-09-09 | 2016-04-28 | Melinta Therapeutics Inc | Antimicrobial compunds and methods of making and using the same |
EP3230259B1 (fr) | 2014-12-08 | 2024-04-03 | The Research Foundation for The State University of New York | Anti-fongiques ciblant la synthèse de shingolipides fongiques |
WO2017193023A1 (fr) * | 2016-05-06 | 2017-11-09 | Melinta Therapeutics, Inc. | Antimicrobiens et leurs procédés de préparation et d'utilisation |
JP2019515041A (ja) * | 2016-05-06 | 2019-06-06 | メリンタ セラピューティクス、 インコーポレイテッドMelinta Therapeutics, Inc. | 抗菌剤ならびにそれを作製および使用する方法 |
IL265109B2 (en) | 2016-09-13 | 2024-05-01 | Allergan Inc | Stabilized Clostridium toxin preparations without protein |
US11414378B2 (en) | 2017-06-16 | 2022-08-16 | The Research Foundation For The State University Of New York | Anti-fungals compounds targeting the synthesis of fungal sphingolipids |
US20210147422A1 (en) * | 2017-06-19 | 2021-05-20 | BioVersys AG | Antimicrobials and methods of making and using same |
US20210403473A1 (en) * | 2018-02-21 | 2021-12-30 | BioVersys AG | Antimicrobial compounds and methods of making and using the same |
WO2019168874A1 (fr) | 2018-02-27 | 2019-09-06 | The Research Foundation For The State University Of New York | Compositions de difluorométhoxylation et de trifluorométhoxylation et leurs procédés de synthèse |
DK3773201T3 (da) * | 2018-03-28 | 2024-10-21 | Dexcom Inc | Sensorkabelstøtteindretning omfattende mekaniske konnektorer |
US20210253577A1 (en) * | 2018-06-06 | 2021-08-19 | BioVersys AG | Biodefense agents |
WO2019234509A2 (fr) * | 2018-06-06 | 2019-12-12 | BioVersys AG | Composés antimicrobiens d'aminométhylamidine et de méthylamidine |
JP2022518229A (ja) * | 2019-01-16 | 2022-03-14 | カーザ グローバル, エルエルシー | 抗菌化合物及び方法 |
US20230072397A1 (en) * | 2019-01-16 | 2023-03-09 | Curza Global, Llc | Antimicrobial Compounds and Methods |
AU2020384885A1 (en) * | 2019-11-13 | 2022-06-09 | Curza Global, Llc | Antimicrobial compounds and methods |
WO2023107487A1 (fr) * | 2021-12-06 | 2023-06-15 | Pretzel Therapeutics, Inc. | Composés inhibiteurs de lonp1, utilisations et méthodes |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2624731A (en) | 1953-01-06 | S-phenylpyrimidkn e x derivativesx | ||
US3980781A (en) | 1966-03-31 | 1976-09-14 | Imperial Chemical Industries Limited | Fungicidal composition and method containing 2-amino-pyrimidines |
US4000138A (en) | 1966-03-31 | 1976-12-28 | Imperial Chemical Industries Limited | Organic compounds and compositions containing them |
US3673184A (en) | 1970-09-02 | 1972-06-27 | Dainippon Pharmaceutical Co | Certain 2-substituted-5,8-dihydro-5-oxopyrido{8 2,3-d{9 pyrimidine-6-carboxylic acid derivatives |
US4361557A (en) | 1980-01-28 | 1982-11-30 | Schering Corporation | 1-Aryl-2-acylamido-3-fluoro-1-propanol acylates, methods for their use as anti-bacterial agents and compositions useful therefor |
EP0067610A1 (fr) | 1981-06-16 | 1982-12-22 | Beecham Group Plc | Pénicillines, un procédé pour leur préparation et compositions les contenant |
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
ZA835684B (en) | 1982-08-27 | 1985-03-27 | Roussel Uclaf | Imidazo(1,2-a)pyrimidines |
US5332835A (en) | 1984-02-03 | 1994-07-26 | Zambon S.P.A. | Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds and new oxazoline compounds useful in this process |
JPS6191184A (ja) | 1984-10-08 | 1986-05-09 | Morishita Seiyaku Kk | 2−アニリノ−5−(1h−テトラゾ−ル−5−イル)ピリミジン−4(3h)−オン誘導体 |
DE3446812A1 (de) | 1984-12-21 | 1986-06-26 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue imidazoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel |
JP2873340B2 (ja) | 1988-04-29 | 1999-03-24 | 武田薬品工業株式会社 | 抗生物質tan―1057,その製造法および用途 |
JP2549931B2 (ja) | 1990-01-12 | 1996-10-30 | 株式会社大塚製薬工場 | ピリミドベンズイミダゾール誘導体 |
JP2991382B2 (ja) | 1990-07-18 | 1999-12-20 | 大日本製薬株式会社 | 縮合三環式化合物およびその塩 |
JP2811230B2 (ja) | 1990-10-17 | 1998-10-15 | コニカ株式会社 | 新規な写真用カプラー |
US5208141A (en) | 1990-10-09 | 1993-05-04 | Konica Corporation | Silver halide color photographic light-sensitive material |
US5958930A (en) | 1991-04-08 | 1999-09-28 | Duquesne University Of The Holy Ghost | Pyrrolo pyrimidine and furo pyrimidine derivatives |
US6451968B1 (en) | 1991-05-24 | 2002-09-17 | Isis Pharmaceuticals, Inc. | Peptide nucleic acids |
US5766855A (en) | 1991-05-24 | 1998-06-16 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity and sequence specificity |
US5434257A (en) | 1992-06-01 | 1995-07-18 | Gilead Sciences, Inc. | Binding compentent oligomers containing unsaturated 3',5' and 2',5' linkages |
US5646163A (en) | 1992-10-30 | 1997-07-08 | The Procter & Gamble Company | Quinolone 5-(N-heterosubstituted amino) antimicrobials |
BR9406662A (pt) | 1993-05-12 | 1996-02-06 | Du Pont | Composto metodo de controle de doenças de plantas composição fungicida e método de controle de mildio de pó de trigo |
US5502177A (en) | 1993-09-17 | 1996-03-26 | Gilead Sciences, Inc. | Pyrimidine derivatives for labeled binding partners |
US5668127A (en) | 1995-06-26 | 1997-09-16 | Pathogenesis Corporation | Nitroimidazole antibacterial compounds and methods of use thereof |
TW424090B (en) | 1995-08-18 | 2001-03-01 | Nat Science Council | Pyrimidines as folate antimetabolites with selective activity against human brain cancer |
US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
US7282327B2 (en) | 1996-01-23 | 2007-10-16 | Affymetrix, Inc. | Nucleic acid labeling compounds |
GB9708611D0 (en) | 1997-04-28 | 1997-06-18 | Univ Cardiff | Chemical compounds |
EP1003727A1 (fr) | 1997-08-07 | 2000-05-31 | Research Corporation Technologies | Antibiotique contre une bacterie resistante a la methicilline |
ATE284407T1 (de) | 1997-11-07 | 2004-12-15 | Isis Pharmaceuticals Inc | Pyrimidinderivate als markierte bindungspartner |
US6028183A (en) | 1997-11-07 | 2000-02-22 | Gilead Sciences, Inc. | Pyrimidine derivatives and oligonucleotides containing same |
DE19838998A1 (de) | 1998-08-27 | 2000-03-09 | Bayer Ag | Neue Naturstoffderivate |
SE9903894D0 (sv) | 1999-10-28 | 1999-10-28 | New Pharma Research Ab | Novel compounds |
EP1113008A1 (fr) | 1999-12-29 | 2001-07-04 | Pfizer Products Inc. | Derives de 4-oxo-2-ureido-1,4,5,6-tetrahydropyrimidine utiles comme agents antibacteriens et antiprotozoaires |
KR100358083B1 (ko) | 2000-02-17 | 2002-10-25 | 에스케이케미칼주식회사 | 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도 |
KR20040028657A (ko) | 2000-10-18 | 2004-04-03 | 파마셋, 리미티드 | 바이러스 감염 및 비정상적인 세포 증식의 치료를 위한변형된 뉴클레오시드 |
DE10061542A1 (de) | 2000-12-11 | 2002-06-13 | Bayer Ag | Alkanoylamino-pyrimidine |
DE10061541A1 (de) | 2000-12-11 | 2002-06-20 | Bayer Ag | Arylamino-Dihydropyrimidinone |
DE10061537A1 (de) | 2000-12-11 | 2002-06-20 | Bayer Ag | beta-Alanin-Derivate |
DE10061538A1 (de) | 2000-12-11 | 2002-06-20 | Bayer Ag | Ureido-Dihydropyrimidinone |
DK1341781T3 (da) | 2000-12-14 | 2005-12-05 | Procter & Gamble | Antimikrobielle quinoloner |
US6900215B2 (en) | 2000-12-15 | 2005-05-31 | Merck Sharp & Dohme Ltd. | Imidazo-pyrimidine derivatives as ligands for gaba receptors |
CA2436665C (fr) | 2001-01-29 | 2012-01-10 | Bio-Rad Laboratories, Inc. | Derives d'acide nucleique |
TWI248936B (en) | 2001-03-21 | 2006-02-11 | Merck Sharp & Dohme | Imidazo-pyrimidine derivatives as ligands for GABA receptors |
US20030207804A1 (en) | 2001-05-25 | 2003-11-06 | Muthiah Manoharan | Modified peptide nucleic acids |
EP1499627A2 (fr) | 2001-07-03 | 2005-01-26 | ISIS Pharmaceuticals, Inc. | Oligonucleotides chimeres resistants a la nuclease |
US20030158403A1 (en) | 2001-07-03 | 2003-08-21 | Isis Pharmaceuticals, Inc. | Nuclease resistant chimeric oligonucleotides |
DE10133277A1 (de) | 2001-07-09 | 2003-01-23 | Bayer Ag | ß-Alanin-Derivate |
DE10141271A1 (de) | 2001-08-23 | 2003-03-06 | Bayer Ag | Neue Tetrahydro-1,3,5-triazin-2-on-Derivate und ihre Verwendung |
JP4306206B2 (ja) | 2001-09-04 | 2009-07-29 | 住友化学株式会社 | イミダゾ[1,2−a]ピリミジン、その用途およびその製造中間体 |
DE10208256A1 (de) | 2002-02-26 | 2003-09-04 | Bayer Ag | Piperidinouracile |
GB0205165D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
IL163749A0 (en) | 2002-03-08 | 2005-12-18 | Schering Plough Ltd | Novel florfenicol-type antibiotics |
PA8595001A1 (es) | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
WO2004080466A1 (fr) | 2003-03-07 | 2004-09-23 | Ribapharm Inc. | Analogues de la cytidine et methodes d'utilisation |
EP1660500B1 (fr) | 2003-07-30 | 2007-12-12 | Laboratorios S.A.L.V.A.T., S.A. | Imidazopyrimidines substituees pour la prevention et le traitement du cancer |
CN1867570A (zh) | 2003-08-12 | 2006-11-22 | 艾其林医药公司 | 作为抗感染试剂的异噻唑喹诺酮及其相关化合物 |
RU2358975C2 (ru) | 2003-08-26 | 2009-06-20 | Тейдзин Фарма Лимитед | Пирролопиримидиноновые производные |
TW200524880A (en) | 2003-10-21 | 2005-08-01 | Sankyo Co | Pyrimidine compounds |
WO2006002627A2 (fr) | 2004-06-30 | 2006-01-12 | Zgene A/S | Enzymes de desoxycytidine du poulet et de desoxyadenosine kinase et leur utilisation |
CA2616768C (fr) | 2005-07-27 | 2014-05-06 | Achillion Pharmaceuticals, Inc. | 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones et composes afferents comme agents anti-infectieux |
EP1951680A4 (fr) | 2005-11-15 | 2011-08-10 | Astrazeneca Ab | Nouveaux derives de 2-aminopyrimidinone et leur utilisation |
NZ544187A (en) | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
JP2007270087A (ja) | 2006-03-31 | 2007-10-18 | Fujifilm Corp | 硬化性組成物、インク組成物、インクジェット記録方法、印刷物、平版印刷版の製造方法、及び平版印刷版 |
ATE496766T1 (de) | 2006-03-03 | 2011-02-15 | Fujifilm Corp | Härtbare zusammensetzung, tintenzusammensetzung, tintenstrahlaufzeichnungsverfahren und flachdruckplatte |
WO2007101871A1 (fr) | 2006-03-08 | 2007-09-13 | Basf Se | Imidazolopyrimidines substituées, procédés de production associés et leur utilisation pour lutter contre des champignons nuisibles, et agents les contenant |
ES2610398T3 (es) | 2006-07-03 | 2017-04-27 | Sk Chemicals, Co., Ltd. | Sales de derivados de pirrolopirimidinona y procedimiento para su preparación |
KR20080003599A (ko) | 2006-07-03 | 2008-01-08 | 에스케이케미칼주식회사 | 피롤로피리미디논 유도체의 겐티세이트 염 및 이의제조방법 |
US20100112561A1 (en) | 2006-08-25 | 2010-05-06 | Stefan Lutz | Fluorescent nucleoside analogues |
CN101528749B (zh) | 2006-09-07 | 2013-07-31 | 工业研究有限公司 | 核苷磷酸化酶和水解酶的无环胺抑制剂 |
WO2008106226A2 (fr) | 2007-02-28 | 2008-09-04 | Rib-X Pharmaceuticals, Inc. | Composés macrolides et procédés de fabrication et d'utilisation de ceux-ci |
EP1964841A1 (fr) | 2007-02-28 | 2008-09-03 | sanofi-aventis | Imidazo[1,2-a]azine et son utilisation en tant que produit pharmaceutique |
MX2009009540A (es) | 2007-03-07 | 2009-09-16 | Alantos Pharm Holding | Inhibidores de metaloproteasa que contienen una porcion heterociclica. |
JP2008222557A (ja) | 2007-03-08 | 2008-09-25 | Kotobuki Seiyaku Kk | ピロロ[3,2−d]ピリミジン誘導体及びこれを有効成分とする医薬組成物 |
BRPI0812297A2 (pt) | 2007-05-30 | 2014-11-25 | Schering Plough Ltd | Processo de preparação de compostos aminodiol, protegidos por oxazolina úteis como intermediários para flofenicol |
ES2602615T3 (es) | 2007-06-12 | 2017-02-21 | Achaogen, Inc. | Agentes antibacterianos |
MX2009013686A (es) | 2007-06-13 | 2010-01-27 | Univ Northeastern | Compuestos antibioticos. |
GB0724342D0 (en) | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
KR20090098710A (ko) | 2008-03-14 | 2009-09-17 | 주식회사 씨티아이바이오 | 세포투과성과 핵산 결합력이 좋은 펩타이드 핵산 유도체 |
TW201033213A (en) | 2009-01-27 | 2010-09-16 | Takeda Pharmaceutical | Fused ring compound and use thereof |
AU2010221419B2 (en) | 2009-03-02 | 2015-10-01 | Alnylam Pharmaceuticals, Inc. | Nucleic acid chemical modifications |
WO2011017319A1 (fr) | 2009-08-03 | 2011-02-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Méthodes de traitement de troubles associés à la polymérisation d'une protéine |
US20120263646A1 (en) | 2009-10-15 | 2012-10-18 | Guerbet | Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases |
DK2488532T3 (en) | 2009-10-16 | 2018-08-13 | Melinta Therapeutics Inc | ANTIMICROBIAL COMPOUNDS AND PROCEDURES FOR PREPARING AND USING THE SAME |
NZ623384A (en) | 2009-10-16 | 2016-06-24 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
KR20190044136A (ko) | 2009-10-16 | 2019-04-29 | 멜린타 서브시디어리 코프. | 항미생물성 화합물 및 이의 제조 방법 및 사용 방법 |
CA2777741A1 (fr) | 2009-10-16 | 2011-04-21 | Rib-X Pharmaceuticals, Inc. | Composes antimicrobiens et methodes de realisation et d'utilisation de ceux-ci |
CA2829993A1 (fr) | 2011-03-15 | 2012-09-20 | Rib-X Pharmaceuticals, Inc. | Agents antimicrobiens |
JP6317669B2 (ja) * | 2011-04-15 | 2018-04-25 | メリンタ セラピューティクス インコーポレイテッド | 抗菌化合物ならびにそれを作製および使用する方法 |
CA2923179A1 (fr) | 2013-09-09 | 2015-03-12 | Melinta Therapeutics, Inc. | Composes antimicrobiens et procedes de fabrication et methodes d'utilisation de ceux-ci |
SG11201601654TA (en) * | 2013-09-09 | 2016-04-28 | Melinta Therapeutics Inc | Antimicrobial compunds and methods of making and using the same |
-
2016
- 2016-03-11 AU AU2016228584A patent/AU2016228584A1/en not_active Abandoned
- 2016-03-11 US US15/557,007 patent/US10947237B2/en active Active
- 2016-03-11 EP EP16762682.9A patent/EP3268370A4/fr not_active Withdrawn
- 2016-03-11 MX MX2017011616A patent/MX2017011616A/es unknown
- 2016-03-11 KR KR1020177028697A patent/KR20180015114A/ko unknown
- 2016-03-11 EA EA201792006A patent/EA201792006A1/ru unknown
- 2016-03-11 MA MA042055A patent/MA42055A/fr unknown
- 2016-03-11 JP JP2017547387A patent/JP2018507881A/ja active Pending
- 2016-03-11 WO PCT/US2016/022216 patent/WO2016145417A1/fr active Application Filing
- 2016-03-11 CA CA2979342A patent/CA2979342A1/fr not_active Abandoned
- 2016-03-11 SG SG11201707346RA patent/SG11201707346RA/en unknown
- 2016-03-11 CN CN201680027468.7A patent/CN107922418A/zh active Pending
- 2016-03-11 BR BR112017019349A patent/BR112017019349A2/pt not_active Application Discontinuation
-
2017
- 2017-09-10 IL IL254398A patent/IL254398A0/en unknown
- 2017-09-11 PH PH12017501646A patent/PH12017501646A1/en unknown
-
2018
- 2018-07-17 HK HK18109253.3A patent/HK1249758A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN107922418A (zh) | 2018-04-17 |
KR20180015114A (ko) | 2018-02-12 |
WO2016145417A1 (fr) | 2016-09-15 |
SG11201707346RA (en) | 2017-10-30 |
US20180065966A1 (en) | 2018-03-08 |
AU2016228584A1 (en) | 2017-10-05 |
IL254398A0 (en) | 2017-11-30 |
US10947237B2 (en) | 2021-03-16 |
EP3268370A4 (fr) | 2018-08-22 |
JP2018507881A (ja) | 2018-03-22 |
MX2017011616A (es) | 2018-04-11 |
EA201792006A1 (ru) | 2018-04-30 |
HK1249758A1 (zh) | 2018-11-09 |
EP3268370A1 (fr) | 2018-01-17 |
BR112017019349A2 (pt) | 2018-06-05 |
CA2979342A1 (fr) | 2016-09-15 |
PH12017501646A1 (en) | 2018-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA42055A (fr) | Composés antimicrobiens et procédés de fabrication et d'utilisation de ceux-ci | |
MA49858A (fr) | Composés, compositions et procédés | |
MA43802A (fr) | Matières cellulosiques et procédés de fabrication et d'utilisation de celles-ci | |
MA43827A (fr) | Composés di-nucléotides cycliques et leurs procédés d'utilisation | |
MA50063A (fr) | Composés, compositions et procédés | |
MA49861A (fr) | Composés de benzoxazépine oxazolidinone et leurs procédés d'utilisation | |
MA47576A (fr) | Composés inhibiteurs d'oga bicyclique | |
MA49560A (fr) | Composés cétoniques bicycliques et leurs procédés d'utilisation | |
MA42612A (fr) | Composés hétérocycliques fumagillol, et procédés correspondants de fabrication et d'utilisation | |
MA39915A (fr) | Composés de pladiénolide pyridine et leurs procédés d'utilisation | |
MA48475A (fr) | Procédés de fabrication de niraparib | |
DK3681282T3 (da) | Antimikrobiel belægning | |
MA41296A (fr) | Procédés de transdifférenciation et procédés d'utilisation de ceux-ci | |
MA43271A (fr) | Formulations améliorées de déférasirox et leurs procédés de fabrication | |
MA47167A (fr) | Composés pyrazolopyrimidine et leurs procédés d'utilisation | |
BR112016024667A2 (pt) | composições de revestimento melhorado e processos para fabricação das mesmas | |
MA44680A (fr) | Compositions et procédés pour la production de composés | |
DK3445766T3 (da) | Ny antimikrobiel forbindelse | |
IT201600128200A1 (it) | Composti ad attivita' fungicida | |
MA45926A (fr) | Composés de fumagillol, et leurs procédés de fabrication et d'utilisation | |
UA41619S (uk) | Респіратор | |
FR3084994B1 (fr) | Cage interosseuse | |
FR3084993B1 (fr) | Cage interosseuse | |
UA37095S (uk) | Перев'язувальна пов'язка-бандаж | |
UA38213S (uk) | Респіратор |